Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Laguna Hills, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Laguna Hills, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Sacramento, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Sacramento, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Sacramento, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Sacramento, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Santa Ana, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Santa Ana, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Tustin, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Tustin, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Vista, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Vista, CA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Aurora, CO
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Aurora, CO
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Bridgeport, CT
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bridgeport, CT
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Wilmington, DE
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Wilmington, DE
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Naples, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Naples, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Crystal River, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Crystal River, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Daytona Beach, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Daytona Beach, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Dunnellon, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Dunnellon, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Hollywood, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Hollywood, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Jacksonville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Jacksonville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Jacksonville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Jacksonville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Ocala, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Ocala, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Melbourne, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Melbourne, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Maine Research Associates
mi
from
Auburn, ME
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Maine Research Associates
mi
from
Auburn, ME
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Miami, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Miami, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Port Charlotte, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Port Charlotte, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Rockledge, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Rockledge, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Sarasota, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Sarasota, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Rockdale Medical Research Associates
mi
from
Conyers, GA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Rockdale Medical Research Associates
mi
from
Conyers, GA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Northeast Georgia Heart Center, PC
mi
from
Gainesville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Northeast Georgia Heart Center, PC
mi
from
Gainesville, FL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Bloomington, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bloomington, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Chicago, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chicago, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Rock Island, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Rock Island, IL
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Ft Wayne, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Ft Wayne, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Indianapolis, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Indianapolis, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Muncie, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Muncie, IN
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Des Moines, IA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Des Moines, IA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Florence, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Florence, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Lexington, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Lexington, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
VA North Texas Health Care System
mi
from
Dallas, TX
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
VA North Texas Health Care System
mi
from
Dallas, TX
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Owensboro, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Owensboro, KY
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Alexandria, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Alexandria, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Lafayette, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Lafayette, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Shreveport, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Shreveport, LA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Auburn, ME
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Auburn, ME
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Palmetto Clinical Trial Services
mi
from
Greenville, SC
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Palmetto Clinical Trial Services
mi
from
Greenville, SC
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Columbia, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Columbia, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Salisbury, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Salisbury, MD
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Charles River Medical Associates
mi
from
Natick, MA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Charles River Medical Associates
mi
from
Natick, MA
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Detroit, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Detroit, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Flint, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Flint, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Kalamazoo, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kalamazoo, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Clinical Research Facility
mi
from
Lansing, MI
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients With Permanent Atrial Fibrillation and Additional Risk Factors
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Lansing, MI